Clinical Trial Update: The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Huaier Granule as postoperative adjuvant therapy for resectable pancreatic cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Huaier Granule

Snippet

Sponsor: Xi'an Jiaotong University | Conditions: Pancreatic Cancer Resectable | Phase 4 | Status: RECRUITING